A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma

Clinical trial NCT06781112 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06781112
Sponsor: Weiwei Zhang
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

TPF Immunotherapy Nasopharyngeal Carcinoma Phase II Clinical Study

Start date: 2025-01-20
Primary completion: 2027-12-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.